PNIBLOG

Glioblastoma MDNA55 Trial Medicenna

Pacific Neuroscience Institute, the leading enrollment site for the MDNA55 clinical trial for Glioblastoma, is still open and enrolling eligible patients. This innovative phase 2 study is for the minimally invasive convection-enhanced delivery (CED) of a new bioengineered targeted therapeutic, MDNA55, in adults with recurrent or progressive glioblastoma. Read more.

Wise and Healthy Aging

Adapting to their life changes within a social and supportive structure can be one of the keys leading to older people succeeding in aging gracefully. The value of strong community programs in supporting health and wellbeing in older people cannot be underestimated.

Clinical Trials at Pacific Neuroscience Institute

Pacific Neuroscience Institute opens up two new clinical trials this month, one in Essential Tremor and one in Glioblastoma. Find out more about these new trials as well as the other available open neurological studies.